Amarin Corp Plcuk (AMRN) Enterprise Value Growth (5y) (2015 - 2026)

Amarin Corp Plcuk (AMRN) Enterprise Value Growth (5y) (2015 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Amarin Corp Plcuk 6.77 Bn 6.59 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 19.22%
Dec 31, 2025 9.59%
Sep 30, 2025 21.82%
Jun 30, 2025 2.57%
Mar 31, 2025 5.62%
Dec 31, 2024 -113.54%
Sep 30, 2024 14.61%
Jun 30, 2024 -6.69%
Mar 31, 2024 -129.08%
Dec 31, 2023 13.32%
Sep 30, 2023 9.26%
Jun 30, 2023 4.69%
Mar 31, 2023 -18.72%
Dec 31, 2022 -4.60%
Sep 30, 2022 -156.89%
Jun 30, 2022 -29.66%
Mar 31, 2022 -30.43%
Dec 31, 2021 -35.82%
Sep 30, 2021 -32.45%
Jun 30, 2021 -20.72%